TARDBP and amyotrophic lateral sclerosis: Increasing evidence suggests that cognitive and behavioral impairment in ALS over-laps with pathological and genetic features, as TDP-43 pathologic burden has been associated with cognitive impairment [16, 17] and C9orf72 repeat expansion has been revealed in ALS patients with rapid cognitive decline and poor survival [18, 19].